Weizhizhuo Biotech
微知卓生物
Weizhizhuo Biotech
Biotech/Healthcare
Founded in October 2015, Weizhuo Biotech focuses on biological therapies for severe liver diseases. Its core product, the HepaCure bioartificial liver, is an extracorporeal liver support system.
Latest round: Series B Extension+ (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.